| 51 |
24760190 | Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). | 2014 Apr 23 |
3 |
| 52 |
24908358 | Aspirin may modify tumor microenvironment via antiplatelet effect. | 2014 Aug |
2 |
| 53 |
24958470 | IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. | 2014 Sep 1 |
1 |
| 54 |
25012137 | Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect. | 2014 Sep |
1 |
| 55 |
25139986 | Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. | 2014 Sep 2 |
2 |
| 56 |
25368225 | Current concepts in colorectal cancer prevention with cyclooxygenase inhibitors. | 2014 Nov |
1 |
| 57 |
25612650 | Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species. | 2014 |
2 |
| 58 |
22763923 | Association of COX-2 rs20417 with aspirin resistance. | 2013 Jan |
1 |
| 59 |
23200247 | Hybrid fluorescent conjugates of COX-2 inhibitors: search for a COX-2 isozyme imaging cancer biomarker. | 2013 Jan 1 |
2 |
| 60 |
23434193 | The role of omega-3 derived resolvins in arthritis. | 2013 Jun |
1 |
| 61 |
23786234 | A mechanistic hypothesis for the aspirin-induced switch in lipid mediator production by cyclooxygenase-2. | 2013 Jul 17 |
1 |
| 62 |
23800934 | Aspirin use and risk of colorectal cancer according to BRAF mutation status. | 2013 Jun 26 |
2 |
| 63 |
23810915 | PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review. | 2013 Sep |
1 |
| 64 |
23884755 | Polypharmacy of osteoarthritis: the perfect intestinal storm. | 2013 Nov |
2 |
| 65 |
23955344 | Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer. | 2013 Oct 4 |
2 |
| 66 |
24098505 | Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2. | 2013 |
1 |
| 67 |
22095955 | Aspirin analogues as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, nitric oxide release, molecular modeling, and biological evaluation as anti-inflammatory agents. | 2012 Jan 2 |
1 |
| 68 |
22245433 | Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitors. | 2012 Apr |
1 |
| 69 |
22252409 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. | 2012 Mar |
3 |
| 70 |
22429367 | Aspirin resistance: clinical significance and genetic polymorphism. | 2012 |
1 |
| 71 |
22588264 | Upregulation of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E2 synthase-1 (mPGES-1) in wall of ruptured human cerebral aneurysms: preliminary results. | 2012 Jul |
1 |
| 72 |
23094721 | Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. | 2012 Oct 25 |
3 |
| 73 |
23240010 | Signal transduction pathways (MAPKs, NF-κB, and C/EBP) regulating COX-2 expression in nasal fibroblasts from asthma patients with aspirin intolerance. | 2012 |
4 |
| 74 |
21163909 | Human prostaglandin H synthase (hPHS)-1 and hPHS-2 in amphetamine analog bioactivation, DNA oxidation, and cytotoxicity. | 2011 Mar |
1 |
| 75 |
21435744 | [Aspirin in the prevention of colorectal cancer]. | 2011 May |
1 |
| 76 |
21647198 | Gastrointestinal effects of aspirin. | 2011 Jun 7 |
1 |
| 77 |
21703104 | Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease. | 2011 May-Jun |
1 |
| 78 |
21728052 | COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. | 2011 Nov |
4 |
| 79 |
19633925 | Effects of the inhibition of cyclooxygenase-2 on human esophageal cancer cells: inhibition of cell proliferation and induction of apoptosis. | 2010 Mar |
1 |
| 80 |
19887674 | The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. | 2010 Feb 4 |
4 |
| 81 |
20194532 | Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids. | 2010 Jun |
4 |
| 82 |
20397022 | Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib. | 2010 Jul |
6 |
| 83 |
20427397 | Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention. | 2010 May |
3 |
| 84 |
20436486 | Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. | 2010 Jun |
1 |
| 85 |
20665602 | Hydrogen peroxide regulates glucose-regulated protein 78 expression via a cyclooxygenase-2 dependent mechanism. | 2010 Sep-Oct |
1 |
| 86 |
20697066 | Role of vitamin and mineral supplementation and aspirin use in cancer survivors. | 2010 Sep 10 |
2 |
| 87 |
20864907 | A summary of recent recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. | 2010 Sep |
1 |
| 88 |
21331307 | COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood. | 2010 Oct 21 |
1 |
| 89 |
22396856 | Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin. | 2010 Aug |
1 |
| 90 |
19026633 | Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. | 2009 Jan 5 |
2 |
| 91 |
19046748 | Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. | 2009 Jun |
1 |
| 92 |
19295242 | Aspirin-induced COX-2 overexpression in monocytes of aspirin-intolerant patients. | 2009 |
10 |
| 93 |
19299662 | Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges. | 2009 Feb |
1 |
| 94 |
19306941 | Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice. | 2009 Jul |
1 |
| 95 |
19671906 | Aspirin use and survival after diagnosis of colorectal cancer. | 2009 Aug 12 |
4 |
| 96 |
19755647 | Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial. | 2009 Oct |
2 |
| 97 |
17495879 | Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. | 2008 Jan |
1 |
| 98 |
18058818 | The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo. | 2008 Apr 1 |
1 |
| 99 |
18197933 | COX-2 mRNA expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID. | 2008 |
2 |
| 100 |
18209566 | Protective effects of aspirin against oxidized LDL-induced inflammatory protein expression in human endothelial cells. | 2008 Jan |
1 |